---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-012317"
form_type: "8-K"
ticker: "CATX"
cik: "0000728387"
company_name: "Perspective Therapeutics, Inc."
filed_at: "2025-02-03T23:59:59+00:00"
generated_at: "2026-05-27T04:19:18.852631+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Perspective Therapeutics posts updated corporate presentation; no specific material updates provided

## Summary
- Filed current report on Form 8-K with an updated corporate presentation under Item 8.01.
- Presentation covers business strategy, pipeline, and outlook; no new financial or operational disclosures.
- No earnings, M&A, leadership, or other material event reported in this filing.

## SEC filing metadata
- accession: 0000950170-25-012317
- form_type: 8-K
- ticker: CATX
- cik: 0000728387
- company_name: Perspective Therapeutics, Inc.
- filed_at: 2025-02-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/728387/000095017025012317/0000950170-25-012317-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/728387/000095017025012317/catx-20250203.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-012317
- JSON: https://secwatch.observer/filing/0000950170-25-012317.json
- Plain text: https://secwatch.observer/filing/0000950170-25-012317.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.